Pharmacyclics regains Optrin rights

PCYC regained from Alcon Laboratories (Fort Worth, Texas) global rights to develop and market Optrin motexafin lutetium to

Read the full 182 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE